SPINEMarketGroup

Spine Industry News

2024

Aclarion and ATEC Execute Strategic Partnership Agreement to Advance Commercialization of Nociscan

By

BROOMFIELD, CO, Jan. 08, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, announced today that it has executed a strategic partnership agreement solidifying the previously signed non-binding Letter […]

Sacrix Provides Safe Alternative to Risky Revision Spine Surgery, Publishing Groundbreaking Results in Renowned Spine Journal

By

BURLINGTON, Mass., Jan. 6, 2024 /PRNewswire-PRWeb/ –Sacrix, a pioneer medical device company in outpatient spine surgery solutions, proudly unveils a novel Less Exposure Spine Surgery (LESS) technique that helped patients avoid major and risky revision corrective spine surgery. The clinical results were summarized in a research paper authored by Board-certified Orthopedic Spine surgeons and published through a […]

Orthofix Provides Executive Management Business Update and Appoints Julie Andrews as Chief Financial Officer

By

LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ: OFIX), a leading global spine and orthopedics company, today announced that effective immediately, Massimo Calafiore has assumed the role of President and Chief Executive Officer (CEO) and as a member of the Orthofix Board of Directors. In conjunction with Mr. Calafiore stepping into his role as CEO, the Company […]

We are proud to announce that Centinel Spine will be Sponsor of SPINEMarketGroup again in 2024!

By

Thank you Centinel Spine! On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship! About Centinel Spine, LLC Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most clinically-proven total disc replacement (TDR) […]

Eminent Spine’s 3D Titanium Anterior Lumbar Stand-Alone System Usage Report and Clinical Study

By

Plano, TX, January 04, 2024 –(PR.com)– Eminent Spine received 510(k) approval of their 3D Titanium Anterior Lumbar Interbody Fusion Stand-Alone System in October of 2022. Since then, Eminent Spine has had a total of 40 3D Titanium ALIF Stand-Alone implants used in procedures in patients who were candidates for an Anterior Lumbar Interbody Fusion. The implants also […]

We are proud to announce that Rudischhauser Surgical Instruments and Implants Manufacturing will be Sponsor of SPINEMarketGroup again in 2024!

By

Thank you Rudischhauser Surgical Instruments and Implants Manufacturing!  On behalf of the SPINEMarketGroup team, we would like to thank you for supporting our site again in 2024 through your PLATINUM sponsorship. About Rudischhauser Surgical Instruments and Implants Manufacturing Your partner and OE-Manufacturer of superior instruments, implants and complete set configurations for spinal, orthopaedic and trauma […]

Exciting FDA-Approved Products in the Pipeline for 2024: A Glimpse into the Dynamic Landscape of American Companies

By

With numerous FDA approvals, 2023 has proven to be a landmark year that paves the way for groundbreaking products. As we move into 2024, the spotlight is on American companies, particularly trailblazers like Eminent Spine and Astura Medical, which have been spearheading the approval process and already have captivating portfolios. Eminent Spine, a leading figure […]

LEM Surgical AG Secures CHF 22 Million in Series B Funding to Ready Robotic System for FDA Submission

By

BERN, Switzerland, January 4, 2024 (Newswire.com) – LEM Surgical AG, an innovative surgical robotics company headquartered in Bern, Switzerland, announces the successful completion of its Series B funding, securing CHF 22 million. The round, which was strongly oversubscribed, reflects the strong investors’ confidence in LEM Surgical’s differentiated approach. This substantial funding boost is attributed to the […]

Cerapedics Files Final Module of the PMA Application for FDA Approval of a new P-15 Peptide Enhanced Bone Graft for Lumbar Spine Fusion

By

WESTMINSTER, Colo., Jan. 4, 2024 /PRNewswire/ — Cerapedics Inc., a commercial-stage orthopedics company dedicated to redefining the standard of care for bone repair, today announced that it has filed the final module in the Pre-Market Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for its investigational P-15 Peptide Enhanced Bone Graft. Cerapedics was able […]

Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2

By

KEELE, England, Jan. 4, 2024 /PRNewswire/ — Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft tissue, is pleased to announce that its investee company, Renovos Biologics (Renovos), has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA) for its lead product, […]

Globus Medical Inc. Cleared of Patent Infringement Allegations in Spinal Surgery Case

By

In a legal saga that began in November 2019, a Maryland neurosurgeon’s company, Moskowitz Family LLC, initiated legal action against medical device giant Globus Medical Inc. The lawsuit alleged patent infringement related to advancements in spinal surgery, focusing on innovations and developments by Dr. Nathan C. Moskowitz and his sons Mosheh and Ahmnon.Moskowitz sought damages […]

Revolutionizing Spine Surgery: The Rise of Awake Spine Surgery

By

The field of spine surgery is continuously evolving, with advancements in tools such as robotics, imaging, and artificial intelligence contributing to safer and faster procedures. We’ve also discussed emerging approaches, materials, and implants. However, in the ever-evolving field of spine surgery, advancements continue to redefine traditional practices, and one such groundbreaking development is the emergence […]

CGBio’s ‘NOVOSIS PUTTY’ Receives FDA ‘Breakthrough Device Designation,’ Accelerate Entry into the US Market

By

SEOUL, South Korea, Jan. 2, 2024 /PRNewswire/ — CGBio (CEO Hyun Seung Yu), a Korean company specializing in bio-regenerative medicine, announced on the 2nd that its advanced bone substitute material, “NOVOSIS PUTTY”, has been granted ‘Breakthrough Device Designation’ (BDD) by the U.S. Food and Drug Administration (FDA). This material incorporates recombinant human bone morphogenetic protein 2 (rhBMP-2). On September […]